Steps forward in regulatory pathways for acute and chronic heart failure-Reference-Cited by-同舟云学术

Steps forward in regulatory pathways for acute and chronic heart failure

Published:2015-01 Issue:1 Volume:17 Page:3-8
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Pani Luca¹,Pecorelli Sergio¹,Rosano Giuseppe¹²³,Anker Stefan D.⁴,Peracino Andrea⁵,Fregonese Laura⁶,Prasad Krishna⁷⁸,Rasi Guido⁶⁹

Affiliation:

1. Italian Medicines Agency-AIFA; Rome Italy

2. Cardiovascular and Cell Sciences Research Institute; St George's University; London UK

3. IRCCS San Raffaele; Rome Italy

4. Department of Innovative Clinical Trials; University Medical Centre Göttingen; Göttingen Germany

5. Fondazione Giovanni Lorenzini Medical Science Foundation; Milan, Italy and Houston USA

6. European Medicines Agency-EMA; London UK

7. Medicines and Healthcare Products Regulatory Agency-MHRA; London UK

8. St Thomas' Hospital; London UK

9. Department of Experimental Medicine and Surgery, School of Medicine and Surgery; University of Tor Vergata; Rome Italy

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference19 articles.

1. Acute heart failure syndromes: Current state and framework for future research;Gheorghiade;Circulation,2005

2. Novel therapeutic targets for the treatment of heart failure;Tamargo;Nat Rev Drug Discov,2011

3. What are the costs of heart failure?;Braunschweig;Europace,2011

4. Progress or lack of progress in hospitalized heart failure;Vaduganathan;Expert Rev Cardiovasc Ther,2013

5. Note for Guidance on Clinical Investigation of Medicinal Products for the Treatment of Cardiac Failure http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003338.pdf 2004

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical trial design, endpoints and regulatory considerations in heart failure;Global Cardiology;2024-03-28

2. Characterization of Oxidative Stress in Chicken Heart Tissue by High-Performance Liquid Chromatography with Ultraviolet‐Visible (HPLC–UV–Vis) Detection;Analytical Letters;2018-09-20

3. Drugs’ development in acute heart failure: what went wrong?;Heart Failure Reviews;2018-05-08

4. Development and psychometric evaluation of the Thirst Distress Scale for patients with heart failure;European Journal of Cardiovascular Nursing;2017-08-25

5. Pharmacokinetics and pharmacodynamics of cardiovascular drugs in chronic heart failure;International Journal of Cardiology;2016-12